Acute myeloid leukemia (AML) is a cancer that evolves from the proliferation of undifferentiated myeloid lineage cells which acquire sequential mutations. Somatic and gene mutations have been associated with the evolution of AML, but understanding the clonal architecture provides insight into which mutations are disease drivers and which are more informative of diagnosis, treatment response, and prognosis. Leverage single-cell genomics to reveal missing details that are lost in bulk sequencing. Uncover clonal evolution insights by downloading the Tapestri AML Panel today.
REQUEST A QUOTE
Advance your understanding of the genetic heterogeneity underpinning acute myeloid leukemia by targeting 20 genes with 127 amplicons for single-cell DNA sequencing. Covering a combination of oncogenes and tumor suppressor genes, the Tapestri AML Panel is designed to cover some of the most commonly mutated genes associated with AML.
DOWNLOAD DATASHEET
Using an AI-powered design, this AML Panel was developed by our experienced multidisciplinary team. You can expect high panel uniformity, amplicon completeness, and cell completeness from your Tapestri single-cell DNA sequencing experiments.
Use Tapestri Designer to add or remove content from existing catalog panels and make this panel your own with content that is relevant to your research. Or start from scratch and upload your human (hg19) or mouse (mm10) targets using gene names, genomic coordinates, or SNV IDs. Target anywhere in the whole human or mouse genome and advance your research with targeted single-cell DNA sequencing.
DESIGN PANEL
